Tag Archives: FDA

Regulating Dietary Supplements: The DMAA Debate

Last week, the Archives of Internal Medicine published a commentary advocating more government regulation of dietary supplements.  Dietary supplements refer to non-vitamin, non-mineral products such as herbals.  The market for these products has steadily risen over the years and, in … Continue reading

Posted in Articles | Tagged , , , , , , , , , | Leave a comment

Patents on “reinvented” medications lead to higher insurance premiums

This Friday’s Wall Street Journal (June 22,2012) features an article authored by Jonathan D. Rockoff reporting that Abbott Laboratories is contesting a portion of the healthcare law regarding patent protection. Patent protections for the drug industry have a long history. … Continue reading

Posted in Politics | Tagged , , , , , , | 4 Comments

Does marijuana have any medical indications?

On June 14th I was driving to work in the morning and heard an NPR piece about the medical marijuana market. I found myself asking, “How has the debate of legalizing marijuana been successfully sold to the public on the … Continue reading

Posted in Articles | Tagged , , , , , , | 2 Comments

Prostate Cancer Screening Controversy-11/26/2011

For years, the FDA recommendation for annual prostate cancer screening has been digital prostate exams along with the PSA (Prostate-specific antigen) blood test annually starting at age 50.  Recently, there has been a U.S. Preventive Services Task Force draft recommendation … Continue reading

Posted in News | Tagged , , , , , | Leave a comment